Eribulin Efficacy on Brain Metastases in Heavily Pretreated Patients with Metastatic Breast Cancer.

Renaud SabatierJohan MartinCécile VicierMathilde GuérinAudrey MonneurMagali ProvansalLouis TassyCarole TarpinJean-Marc ExtraFrédéric ViretAnthony Goncalves

Published in: Journal of clinical medicine (2021)

Eribulin seems to have only a limited impact on BM evolution. Hormone receptors expression may identify a subset of patients with better BM control.

Keyphrases

metastatic breast cancer
brain metastases
small cell lung cancer
poor prognosis
binding protein
randomized controlled trial
long non coding rna
study protocol
open label